DARPA Funds Wearable Brain Interfaces

DARPA funds Next-Generation Nonsurgical Neurotechnology (N3) program to make wearable brain interfaces. Battelle Memorial Institute, Carnegie Mellon University, Johns Hopkins University Applied Physics Laboratory, Palo Alto Research Center (PARC), Rice University, and Teledyne Scientific are leading multidisciplinary teams to develop high-resolution, bidirectional brain-machine interfaces for use by able-bodied service members. These wearable interfaces could ultimately …

Read more

Nuclear Fusion Company TAE Technologies First Product is a Better Cancer Radiation Treatment Device

TAE Life Sciences, division of TAE Technologies, will use low energy neutrons to destroy cancer tumors without damaging healthy tissue. They are using nuclear science know-how that they have built up from their continuing pursuit of commercial nuclear fusion to develop a more effective million cancer radiation treatment device. TAE raised $40 million to build …

Read more

Hewlett Packard Enterprise Has Bought Cray and Will Push to ExaFLOP Supercomputers

Hewlett Packard Enterprise (HPE) has bought Cray Supercomputers. Cray Research was started in 1972 by the legendary supercomputer expert Seymour Cray. HPE and Cray want to lead in the Exascale era. The promise of Exascale is more than a single gigantic supercomputer or a performance milestone. It is the ability to take advantage of the …

Read more

Holo4Labs Makes Minority Report’s Mixed Reality Data Processing Real

Mixed reality data processing has moved from the realm of science fiction films like The Minority Report into real-life science labs, thanks to a recent Microsoft HoloLens app, announced by polish IT company Solution4Labs. Solution4Labs will customize the HoloLens VR experience, using the Holo4Labs app. Abiding by principles of digital automation and mixed reality, the …

Read more

Wearable Cancer Detection Tests 1-2% of Blood Over 2 Hours

Tests of a wearable cancer detection system are very positive. The system continuously collects CTCs directly from a peripheral vein. The system returns the remaining blood products after CTC enrichment, permitting testing of larger blood volumes than classic phlebotomy specimens over a prolonged period of time. The system is validated in canine models showing capability to screen 1–2% of the entire blood over 2 hours. This is about seven times more than a regular blood draw.